Find a Professional

PublicationsFind a Professional
{ Banner Photo }

Regulatory and Compliance Implications of Orphan Drugs

November 24, 2014
Edward J. Buthusiem and Gary F. Miller, Jr.
Pharmaceutical Compliance Monitor

Edward Buthusiem and Gary Miller write about drug development and compliance, the Orphan Drug Act, and potential program incentives.

Read the article.

Related Professionals